The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Plutus Capital Management LLP
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Plutus Capital Management LLP, a non-promoter entity, has acquired 3,75,000 equity shares of Ganga Pharmaceuticals Ltd, taking its holding from nil to 7.75% of the company's share capital (6.34% on a diluted basis). The shares were allotted on July 17, 2025 through the conversion of previously issued convertible warrants, and this is a revised disclosure filed under SEBI Takeover Regulations. Following this allotment, the company's total equity capital expanded from Rs. 4.84 crore to Rs. 5.91 crore (an increase of about 10.75 lakh shares). Plutus Capital Management LLP has explicitly stated it does not belong to the promoter or promoter group of the company.
This is a non-promoter investor increasing its stake meaningfully above the 5% disclosure threshold, which adds a new institutional shareholder to the company's register. For retail investors, this signals fresh capital interest in the stock and possible dilution from the warrant conversion, though the acquirer's non-promoter status means it is not a promoter-driven confidence signal.